The resistance mechanism of 49 Enterobacteriaceae isolates with decreased susceptibility to carbapenems collected from 2004 to 2008 at 16 teaching hospitals in China was investigated. Moderate-to high-level carbapenem resistance in most isolates was more closely associated with loss or decreased expression of both major porins combined with production of AmpC or extended-spectrum -lactamase enzymes, while KPC-2, IMP-4, and IMP-8 carbapenemase production may lead to a low to moderate level of carbapenem resistance in Enterobacteriaceae in China.To date, the emergence of carbapenem-resistant Enterobacteriaceae has been reported in some countries (7,9,16,19). Carbapenemases and porin loss combined with AmpC enzyme hyperproduction are regarded as the main mechanisms of resistance (7,9,12,19). In China, there have been some reports of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae, Serratia marcescens, and Escherichia coli in the city of Hangzhou (2,17,20). However, a nationwide survey has not been performed. In this study, 49 Enterobacteriaceae isolates with decreased susceptibility to carbapenems (MIC of imipenem, meropenem, or ertapenem of Ն2 g/ml) were collected from 16 teaching hospitals in a nationwide distribution, which included 26 K. pneumoniae, 8 E. coli, 10 Enterobacter cloacae, 2 Enterobacter aerogenes, and 3 Citrobacter freundii isolates. Identification of organisms was confirmed by using the API 20E or Vitek2 Compact system (bioMérieux, France). Susceptibility testing was performed by using the agar dilution method according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) (3, 4). Breakpoints for tigecycline were as defined by the FDA (susceptible, Յ2 g/ml; resistant, Ն8 g/ml). Forty-nine isolates were nonsusceptible to most antibiotics except to tigecycline (to which 45 of 49 isolates were susceptible) and polymyxin B (to which 47 of 49 isolates were susceptible).Conjugation experiments were carried out in mixed broth cultures, as described previously (2). Plasmid DNAs of all carbapenemase-producing isolates were obtained with a QIAfilter midikit (Qiagen, Hilden, Germany). Resistance genes were successfully transferred from 23 of 49 isolates to the recipient E. coli C600. Among the 16 carbapenemaseproducing clinical isolates, carbapenemase genes of 13 isolates were successfully transferred to E. coli C600, except for three IMP-4-producing E. cloacae isolates. The 13 carbapenemaseproducing transconjugants showed 8-to 64-fold increases in the MIC of imipenem, 32-to 512-fold increases in the MIC of meropenem, and 256-to 4,096-fold increases in the MIC of ertapenem relative to those of the recipient. Most of the carbapenemase-producing transconjugants harbored a single plasmid, while only one transconjugant (GZ64T) harbored four different plasmids (Table 1).PCR of -lactamase genes for the transconjugants and respective donors was carried in a PTC-200 PCR system (BioRad). The primers used in this study were described previously (1,5,11,12,14,18,19). PCR products were...